GOLDMAN, SACHS & CO. | 361 | Wellington Biomedical Innovation Partners II, L.P. | 1903227 | 01/06/2023 | D/A | Indefinite | $186,005,000 |
GOLDMAN, SACHS & CO. | 361 | Aptitude Partners (Levered) LP | 1677121 | 09/16/2020 | D/A | Indefinite | $185,863,505 |
GOLDMAN, SACHS & CO. | 361 | Apollo Navigator Aviation Offshore Fund I, L.P. | 1782526 | 02/24/2021 | D/A | Indefinite | $184,330,000 |
GOLDMAN, SACHS & CO. | 361 | Goldman Sachs Hedge Fund Opportunities Institutional Ltd | 1367809 | 11/09/2010 | D/A | Indefinite | $183,834,125 |
GOLDMAN, SACHS & CO. | 361 | Goldman Sachs Commodities Fund LLC | 1318425 | 02/09/2010 | D/A | Indefinite | $183,151,723 |
GOLDMAN, SACHS & CO. | 361 | Apollo Navigator Aviation Offshore Fund I, L.P. | 1782526 | 05/22/2020 | D/A | Indefinite | $182,750,000 |
GOLDMAN, SACHS & CO. | 361 | LSV: Non-US Equity Offshore L P | 1359244 | 09/22/2015 | D/A | Indefinite | $182,217,500 |
GOLDMAN, SACHS & CO. | 361 | LSV: Non-US Equity Offshore L P | 1359244 | 09/22/2016 | D/A | Indefinite | $182,217,500 |
GOLDMAN, SACHS & CO. | 361 | LSV: Non-US Equity Offshore L P | 1359244 | 09/15/2017 | D/A | Indefinite | $182,217,500 |
GOLDMAN, SACHS & CO. | 361 | LSV: Non-US Equity Offshore L P | 1359244 | 09/14/2018 | D/A | Indefinite | $182,217,500 |